Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation. [electronic resource]
Producer: 20030318Description: 43-5 p. digitalISSN:- 0001-5792
- Anemia, Hemolytic, Autoimmune -- drug therapy
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD19 -- blood
- B-Lymphocytes -- cytology
- Female
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Hemoglobins -- metabolism
- Humans
- Infant
- Lymphocyte Depletion -- adverse effects
- Mucopolysaccharidosis I -- complications
- Rituximab
- T-Lymphocytes
- Transplantation Chimera
- Transplantation, Homologous -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.